Are GLP-1s Performance-Enhancing Drugs?
The use of GLP-1 weight-loss medications by elite athletes like Serena Williams has sparked a debate over whether these drugs should be classified as performance-enhancing substances. Experts are currently divided on the ethical and competitive implications of their use in sports.
Why it matters
This debate could lead to new regulations in professional sports, impacting how athletes manage their health and performance.
A weight-loss medication eased Serena Williams’s comeback. Experts can’t agree on whether that’s doping.
The article presents multiple perspectives on a complex issue without taking a definitive stance.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in